Spravato vs. IV Ketamine Infusion: Which Is Right for You?
Both Spravato (esketamine) and IV ketamine are effective treatments for depression and related conditions, but they differ in FDA approval status, cost, insurance coverage, convenience, and treatment experience.
FDA Approval
This is the most significant regulatory difference. Spravato received FDA approval in 2019 for treatment-resistant depression and in 2020 for major depressive disorder with acute suicidal ideation. IV ketamine is used entirely off-label for psychiatric conditions, though it has been used clinically since the 1970s with robust evidence for effectiveness. FDA approval affects insurance coverage more than clinical efficacy.
Insurance Coverage
Spravato is frequently covered by commercial insurance, Medicare Part B, and some Medicaid plans with prior authorization. Patient out-of-pocket costs can be as low as $0-$150 per session. IV ketamine is almost never covered by insurance and is entirely out-of-pocket, typically $400-$800 per session.
Efficacy
Both treatments show approximately 50-70% response rates in treatment-resistant depression. Direct head-to-head comparisons are limited. IV ketamine may produce faster and more dramatic initial effects due to higher plasma levels and 100% bioavailability, compared to approximately 40-45% bioavailability for intranasal Spravato. Both require maintenance treatment to sustain effects.
The Treatment Experience
IV Ketamine: 40-60 minute infusion in a clinical setting; often produces more intense dissociative experience; 30-60 minute recovery period. Spravato: 2-hour clinic visits (including mandatory observation period); self-administered nasal spray; similar but often less intense effects; cannot drive until next day.
Which Should You Choose?
Choose Spravato if you have qualifying insurance coverage, treatment-resistant depression diagnosis, or prefer an FDA-approved medication. Choose IV ketamine if you need treatment for conditions beyond depression (PTSD, chronic pain, anxiety), lack insurance coverage for Spravato, or want more flexibility in dosing and treatment approach.
Medical Disclaimer: This guide is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting ketamine therapy.